UK markets closed

AERI Aug 2022 15.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.20000.0000 (0.00%)
As of 09:38AM EDT. Market open.
Full screen
Previous close0.2000
Open0.2000
Bid0.0000
Ask0.7500
Strike15.00
Expiry date2022-08-19
Day's range0.2000 - 0.2000
Contract rangeN/A
Volume3
Open interest13
  • Zacks

    After Golden Cross, Aerie Pharmaceuticals (AERI)'s Technical Outlook is Bright

    Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

  • Zacks

    Roche's (RHHBY) sBLA For Polivy Combo Accepted by FDA

    Roche's (RHHBY) sBLA seeking approval for the use of Polivy in combination with R-CHP for previously untreated diffuse large B-cell lymphoma in adults has been accepted in the United States.

  • Business Wire

    Aerie Pharmaceuticals Announces New Employee Inducement Grant

    DURHAM, N.C., August 15, 2022--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), a pharmaceutical company focused on the discovery, development, and commercialization of first-in-class ophthalmic therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases and retinal diseases today announced that the compensation committee of Aerie Pharmaceutical’s board of directors granted one new employee an award totaling 16,900 stock options that will vest over 4 years, with 25% vesti